The finding that IMP2 hepatic overexpression results in steatosis whereas global IMP2 deficiency is accompanied by a marked reduction in hepatic triglyceride suggested that IMP2 may favor liver triglyceride deposition. Here, IGF2BP2 is linked to steatosis.